Bal Pharma Stock

Bal Pharma P/B

The P/B (Price-to-Book Ratio) of Bal Pharma (BALPHARMA.NS) as of Aug 10, 2026 is 1.58. In the previous year, P/B (Price-to-Book Ratio) was 1.70 — a change of -6.99% (lower).

P/B

1.58

YoY

-6.99%

Last updated:

P/B (Price-to-Book Ratio) of Bal Pharma is 2026 1.58 . P/B (Price-to-Book Ratio) of Bal Pharma was 2025 1.70 . It decreases by -6.99% lower compared to the previous year.
Access this data via the Eulerpool API

Bal Pharma Stock analysis

What does Bal Pharma do? Bal Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bal Pharma stock

P/B (Price-to-Book Ratio) of Bal Pharma is 1.58 in 2026.

P/B (Price-to-Book Ratio) of Bal Pharma changed from 1.70 to 1.58, representing a -6.99% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Bal Pharma since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Bal Pharma with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Bal Pharma

All Key Metrics — Bal Pharma